Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

New cyclooxygenase inhibitors.

S Vasoo¹, S C Ng

¹Rheumatology Section, Department of Medicine, National University Hospital.

Annals of the Academy of Medicine, Singapore

|May 31, 2001

Summary

New cyclooxygenase-2 (COX-2) inhibitors offer effective inflammation and pain relief with fewer gastrointestinal issues than traditional NSAIDs. However, they do not protect the kidneys or heart and require further study for long-term safety and cost-effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gut microbiota in the pathogenesis of COVID-19: viral replication and transmission (abridged secondary publication).

Hong Kong medical journal = Xianggang yi xue za zhi·2025

Same author

Diet outperforms microbial transplant to drive microbiome recovery in mice.

Nature·2025

Same author

Pathogenic bacteria rapidly colonize sinks of a neonatal intensive care unit: results of a prospective surveillance study.

The Journal of hospital infection·2025

Same author

Whole-genome sequencing establishes persistence of biofilm-associated Pseudomonas aeruginosa detected from microbiological surveillance of gastrointestinal endoscopes.

The Journal of hospital infection·2024

Same author

Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.

The Medical journal of Malaysia·2024

Same author

<math></math> La<sub>max</sub>: determining the optimal test duration for maximal lactate formation rate during all-out sprint cycle ergometry.

European journal of applied physiology·2024

Area of Science:

Pharmacology
Drug Development
Inflammation and Pain Management

Background:

Discovery of cyclooxygenase (COX) isoforms (COX-1 and COX-2) led to a new class of NSAIDs.
COX-2 inhibitors demonstrate efficacy comparable to traditional NSAIDs with reduced gastrointestinal side effects.

Purpose of the Study:

Provide historical background on cyclooxygenase inhibitors.
Discuss the pharmacology of COX inhibitors.
Review the latest updates on COX-2 inhibitors.

Main Methods:

Conducted a MEDLINE search of medical journals from 1990-2000.
Reviewed randomized controlled trials, meta-analyses, and review articles.

Main Results:

COX-2 inhibitors are widely accepted for treating inflammation and pain.
These drugs cause fewer gastrointestinal side effects compared to traditional NSAIDs.

Conclusions:

COX-2 inhibitors are not renal sparing and lack cardioprotective effects.
Safety in NSAID-sensitive patients and cost-effectiveness for chronic conditions require further investigation.
Long-term usage will clarify the overall benefits and drawbacks of COX-2 inhibitors.

Related Experiment Videos